{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:25:58Z","timestamp":1784280358241,"version":"3.55.0"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.cyto.2016.11.010","type":"journal-article","created":{"date-parts":[[2016,12,3]],"date-time":"2016-12-03T01:14:49Z","timestamp":1480727689000},"page":"169-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Interleukin-10: Role in increasing susceptibility and pathogenesis of rheumatic fever\/rheumatic heart disease"],"prefix":"10.1016","volume":"90","author":[{"given":"Neha","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devinder","family":"Toor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2016.11.010_b0005","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(05)66874-2","article-title":"Acute rheumatic fever","volume":"366","author":"Carapetis","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2016.11.010_b0010","first-page":"12","article-title":"The stark reality of rheumatic heart disease","author":"Carapetis","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cyto.2016.11.010_b0015","first-page":"302","article-title":"Guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992: special writing group of the committee on rheumatic fever, endocarditis, and Kawasaki disease of the council on cardiovascular disease in the young","volume":"87","author":"Dajani","year":"1993","journal-title":"Am. Heart Assoc. Circulat."},{"key":"10.1016\/j.cyto.2016.11.010_b0020","first-page":"1","article-title":"Revision of the jones criteria for the diagnosis of acute rheumatic fever in the era of doppler echocardiography a scientific statement from the american heart association","author":"Gewitz","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cyto.2016.11.010_b0025","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(11)61171-9","article-title":"Rheumatic heart disease","volume":"379","author":"Marijon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cyto.2016.11.010_b0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000077915","article-title":"Rheumatic fever: from sore throat to autoimmune heart lesions rheumatic fever: from sore throat to autoimmune heart lesions","volume":"134","author":"Guilherme","year":"2004","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0035","article-title":"Rheumatic fever & rheumatic heart disease: the last 50 years","volume":"1\u201323","author":"Kumar","year":"2014","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.cyto.2016.11.010_b0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0896-8411(03)00079-9","article-title":"Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease","volume":"21","author":"Hernandez-Pacheco","year":"2003","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cyto.2016.11.010_b0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00246-006-0002-7","article-title":"Gene polymorphisms of TNF-alpha(-308), IL-10(-1082), IL-6(-174), and IL-1Ra(VNTR) related to susceptibility and severity of rheumatic heart disease","volume":"28","author":"Settin","year":"2007","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.cyto.2016.11.010_b0050","first-page":"1","article-title":"Interleukin 10 (IL-10) regulatory cytokine and its clinical consequences","author":"Bijjiga","year":"2011","journal-title":"J. Clin. Cell. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease","volume":"29","author":"Ouyang","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0060","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.micinf.2012.07.003","article-title":"Immune responsiveness during disease progression from acute rheumatic fever to chronic rheumatic heart disease","volume":"14","author":"Toor","year":"2012","journal-title":"Microbes Infect."},{"key":"10.1016\/j.cyto.2016.11.010_b0065","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00431-012-1689-5","article-title":"Role of cytokine gene (IFN-\u03b3, TNF-\u03b1, TGF-\u03b21, IL-6, and IL-10) polymorphisms in pathogenesis of acute rheumatic fever in Turkish children","volume":"171","author":"Col-Araz","year":"2012","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.cyto.2016.11.010_b0070","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1007\/s001340051125","article-title":"Cytokine and cytokine receptor polymorphisms in infectious disease","volume":"26","author":"van Deventer","year":"2000","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.cyto.2016.11.010_b0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0896-8411(03)00044-1","article-title":"The complex role of interleukin-10 in autoimmunity","volume":"20","author":"Groux","year":"2003","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cyto.2016.11.010_b0080","first-page":"241","article-title":"Interleukin-10 therapy \u2013 review of a new approach","volume":"55","author":"Asadullah","year":"2003","journal-title":"Med. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.11613\/BM.2015.004","article-title":"Pathologic patterns of interleukin 10 expression \u2013 a review","volume":"25","author":"Trifunovi\u0107","year":"2015","journal-title":"Biochem. Medica"},{"key":"10.1016\/j.cyto.2016.11.010_b0090","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1084\/jem.20070104","article-title":"Interleukin-10 production by effector T cells: Th1 cells show self control","volume":"204","author":"Trinchieri","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2016.11.010_b0095","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","article-title":"Interleukin-10-secreting type 1 regulatory T cells in rodents and humans","volume":"212","author":"Roncarolo","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2016.11.010_b0110","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: the master regulator of immunity to infection","volume":"180","author":"Couper","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0115","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/mt.2012.71","article-title":"Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells","volume":"20","author":"Andolfi","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cyto.2016.11.010_b0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-2776(10)05004-2","article-title":"The family of IL-10-secreting CD4+ T cells","volume":"105","author":"Fujio","year":"2010","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0125","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S1074-7613(00)80404-5","article-title":"Interleukin-10 down-regulates MHC class II \u03b1\u03b2 peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling","volume":"7","author":"Koppelman","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2016.11.010_b0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coi.2014.12.009","article-title":"Suppression of antigen presentation by IL-10","volume":"34","author":"Mittal","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2567.2006.02321.x","article-title":"Mechanisms of immune suppression by interleukin-10 and transforming growth factor-\u03b2: the role of T regulatory cells","volume":"117","author":"Taylor","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2016.11.010_b0140","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3389\/fimmu.2013.00352","article-title":"Rheumatic heart disease: molecules involved in valve tissue inflammation leading to the autoimmune process and anti \u2013 S. pyogenes Vaccine","volume":"4","author":"Guilherme","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10875-009-9332-6","article-title":"Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease","volume":"30","author":"Guilherme","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0150","first-page":"1","article-title":"Rheumatic heart disease: genes, inflammation and autoimmunity","author":"Guilherme","year":"2012","journal-title":"Rheumatol. Curr. Res."},{"key":"10.1016\/j.cyto.2016.11.010_b0155","doi-asserted-by":"crossref","first-page":"15084","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","author":"Carapetis","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.cyto.2016.11.010_b0160","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1126\/science.2578225","article-title":"Myosin: a link between streptococci and heart","volume":"227","author":"Krisher","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.cyto.2016.11.010_b0165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1172\/JCI7132","article-title":"Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin","volume":"106","author":"Galvin","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2016.11.010_b0170","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.4049\/jimmunol.176.9.5662","article-title":"Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease","volume":"176","author":"Fa\u00e9","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0175","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.4049\/jimmunol.152.9.4375","article-title":"Immunological mimicry between N-acetyl-beta-D-glucosamine and cytokeratin peptides. Evidence for a microbially driven anti-keratin antibody response","volume":"152","author":"Shikhman","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0180","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm892","article-title":"Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea","volume":"9","author":"Kirvan","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2016.11.010_b0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/08916930500484757","article-title":"Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham\u2019s chorea","volume":"39","author":"Kirvan","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.cyto.2016.11.010_b0190","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)63415-3","article-title":"Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions","volume":"165","author":"Guilherme","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2016.11.010_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S146239940501015X","article-title":"Molecular pathogenesis of rheumatic fever and rheumatic heart disease","volume":"7","author":"Guilherme","year":"2005","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.cyto.2016.11.010_b0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5935\/1678-9741.20140007","article-title":"IL-10 and ET-1 as biomarkers of rheumatic valve disease","volume":"29","author":"Le\u00e3o","year":"2014","journal-title":"Rev. Bras. Cir. Cardiovasc."},{"key":"10.1016\/j.cyto.2016.11.010_b0205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/hep.510270116","article-title":"Interleukin-10 expression is autoregulated at the transcriptional level in human and murine Kupffer cells","volume":"27","author":"Knolle","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2016.11.010_b0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","article-title":"Role of Interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"Iyer","year":"2012","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0215","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/intimm\/6.12.1927","article-title":"Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice","volume":"6","author":"Morltanl","year":"1994","journal-title":"Int. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0220","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ajpath.2011.04.016","article-title":"Inhibition of fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development","volume":"179","author":"Xiao","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2016.11.010_b0225","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1182\/blood.V88.7.2549.bloodjournal8872549","article-title":"Interleukin-10 increases Bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells","volume":"88","author":"Weber-Nordt","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2016.11.010_b0230","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/rheumatology\/keh083","article-title":"Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody","volume":"43","author":"Ravirajan","year":"2004","journal-title":"Rheumatology"},{"key":"10.1016\/j.cyto.2016.11.010_b0235","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.181.3.839","article-title":"Role of Interleukin-10 in B-lymphocytes hyperactivity and autoantibody production of human systemic lupus erythematosus","volume":"181","author":"Llorente","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2016.11.010_b0240","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.178.3.1041","article-title":"Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor\/IL-12 synthesis in accessory cells","volume":"178","author":"D\u2019Andrea","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2016.11.010_b0245","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1182\/blood.V93.5.1456","article-title":"Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1","volume":"93","author":"Ito","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2016.11.010_b0250","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2567.2005.02107.x","article-title":"Interleukin-10 (IL-10) mediated suppression of IL-12 production in RAW 264.7 cells involves c-rel transcription factor","volume":"114","author":"Rahim","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2016.11.010_b0255","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01543103","article-title":"Biology of human TH1 and TH2 cells","volume":"15","author":"Romagnani","year":"1995","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0260","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/318076","article-title":"Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium","volume":"183","author":"Roberts","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2016.11.010_b0265","first-page":"1007","article-title":"Rheumatic heart disease: 15 years of clinical and immunological follow-up","volume":"3","author":"Sampaio","year":"2007","journal-title":"Vasc. Heal. Risk Manage."},{"key":"10.1016\/j.cyto.2016.11.010_b0270","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.4049\/jimmunol.151.9.4545","article-title":"Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration","volume":"151","author":"Jinquan","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0275","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1128\/jvi.74.10.4729-4737.2000","article-title":"Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8 & cytotoxic T lymphocytes","volume":"74","author":"Santin","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.cyto.2016.11.010_b0280","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.4049\/jimmunol.160.7.3188","article-title":"Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells","volume":"160","author":"Groux","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0285","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1365-2567.1999.00828.x","article-title":"Interleukin-10-induced CD8 cell proliferation","volume":"98","author":"Rowbottom","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2016.11.010_b0290","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.4049\/jimmunol.145.12.4167","article-title":"IL-10, a novel growth cofactor for mature and immature T cells","volume":"145","author":"MacNeil","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0300","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.carpath.2015.07.006","article-title":"Changes in the expression of Th17 cell-associated cytokines in the development of rheumatic heart disease","volume":"24","author":"Wen","year":"2015","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.cyto.2016.11.010_b0305","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2310\/JIM.0000000000000023","article-title":"A shift in the balance of regulatory T and T helper 17 cells in rheumatic heart disease","volume":"62","author":"Bas","year":"2014","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.cyto.2016.11.010_b0310","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/CS20110496","article-title":"IL-17\/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential","volume":"122","author":"Zhu","year":"2012","journal-title":"Clin. Sci."},{"key":"10.1016\/j.cyto.2016.11.010_b0315","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2015.00236","article-title":"Regulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAs","volume":"6","author":"Khan","year":"2015","journal-title":"Front. Genet."},{"key":"10.1016\/j.cyto.2016.11.010_b0320","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1600-065X.2008.00711.x","article-title":"Diversity in the contribution of IL-10 to T-cell-mediated immune regulation","volume":"226","author":"Maynard","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cyto.2016.11.010_b0325","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1038\/bcj.2015.56","article-title":"IL-10 induces the development of immunosuppressive CD14(+)HLA-DR(low\/\u2212) monocytes in B-cell non-Hodgkin lymphoma","volume":"5","author":"Xiu","year":"2015","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.cyto.2016.11.010_b0330","doi-asserted-by":"crossref","DOI":"10.1038\/nature10957","article-title":"Pathogen-induced human TH17 cells produce IFN-\u03b3 or IL-10 and are regulated by IL-1\u03b2","volume":"484","author":"Zielinski","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2016.11.010_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0590-1","article-title":"IL-17\/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia","volume":"13","author":"Musuraca","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cyto.2016.11.010_b0340","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1002\/eji.200838331","article-title":"Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells","volume":"38","author":"Gu","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0345","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.imlet.2009.10.006","article-title":"IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients","volume":"127","author":"Heo","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2016.11.010_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.ihj.2015.08.009","article-title":"Circulating level of regulatory T cells in rheumatic heart disease: an observational study","author":"Mukhopadhyay","year":"2016","journal-title":"Indian Heart J."},{"key":"10.1016\/j.cyto.2016.11.010_b0355","first-page":"118","article-title":"Regulatory T-cell deficiency in rheumatic heart disease: a preliminary observational study","volume":"22","author":"Mukhopadhyay","year":"2013","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.cyto.2016.11.010_b0360","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2567.2012.03584.x","article-title":"The nature of innate and adaptive interleukin-17A responses in sham or bacterial inoculation","volume":"136","author":"Chong","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.cyto.2016.11.010_b0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002252","article-title":"Robust antigen specific th17 t cell response to group a streptococcus is dependent on il-6 and intranasal route of infection","volume":"7","author":"Dileepan","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cyto.2016.11.010_b0370","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/IAI.01152-13","article-title":"Susceptibility to acute rheumatic fever based on differential expression of genes involved in cytotoxicity, chemotaxis, and apoptosis","volume":"82","author":"Bryant","year":"2014","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2016.11.010_b0375","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3855\/jidc.2874","article-title":"Molecular epidemiology and virulence characteristics of prevalent group A streptococci recovered from patients in northern India","volume":"8","author":"Arya","year":"2014","journal-title":"J. Infect. Dev. Countries"},{"key":"10.1016\/j.cyto.2016.11.010_b0380","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4103\/0974-2069.79617","article-title":"Genes, autoimmunity and pathogenesis of rheumatic heart disease","volume":"4","author":"Guilherme","year":"2011","journal-title":"Ann. Pediatr. Cardiol."},{"key":"10.1016\/j.cyto.2016.11.010_b0385","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"IL-23-IL-17 immune axis: discovery, mechanistic understanding, and clinical testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0390","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00005-015-0344-z","article-title":"The role of IL-17 and Th17 lymphocytes in autoimmune diseases","volume":"63","author":"Tabarkiewicz","year":"2015","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.cyto.2016.11.010_b0395","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1128\/CVI.00282-12","article-title":"Differential interleukin-10 (IL-10) and IL-23 production by human blood monocytes and dendritic cells in response to commensal enteric bacteria","volume":"19","author":"Manuzak","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0400","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/eji.200425677","article-title":"IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human","volume":"35","author":"Vanden Eijnden","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0405","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2249.1993.tb05920.x","article-title":"Enhancement of IL-1, IL-2 production and IL-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease; a prospective study","volume":"91","author":"Morris","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0410","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/clin.1995.1140","article-title":"Lymphocyte subsets and plasma IL-1 alpha, IL-2, and TNF-alpha concentrations in acute rheumatic fever and chronic rheumatic heart disease","volume":"77","author":"Narin","year":"1995","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.cyto.2016.11.010_b0415","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/clin.1995.1005","article-title":"Serum-soluble receptors for tumor necrosis factor-alpha and interleukin-2, and neopterin in acute rheumatic fever","volume":"74","author":"Samsonov","year":"1995","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.cyto.2016.11.010_b0420","first-page":"1436","article-title":"Cytokines and immunoglobulin in rheumatic heart disease: production by blood and tonsillar mononuclear cells","volume":"16","author":"Miller","year":"1989","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cyto.2016.11.010_b0425","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s004310050545","article-title":"Cytokines in acute rheumatic fever","volume":"156","author":"Yegin","year":"1997","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.cyto.2016.11.010_b0430","first-page":"113","article-title":"Cytokines as a predictor of progression to valvular disease in children with rheumatic fever","volume":"25","author":"Abul-fadl","year":"2013","journal-title":"J. Saudi Hear. Assoc."},{"key":"10.1016\/j.cyto.2016.11.010_b0435","doi-asserted-by":"crossref","first-page":"4","DOI":"10.54361\/ljmr.v8i1.07","article-title":"Interleukin 8 and tumor necrosis factor- \u03b1 level in acute rheumatic fever and chronic rheumatic heart disease","volume":"8","author":"Benzabya","year":"2014","journal-title":"Libyan J. Med. Res."},{"key":"10.1016\/j.cyto.2016.11.010_b0440","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm1492","article-title":"Interleukin-10 determines viral clearance or persistence in vivo","volume":"12","author":"Brooks","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2016.11.010_b0445","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/745483","article-title":"Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis","volume":"2012","author":"Cavalcanti","year":"2012","journal-title":"Pulm. Med."},{"key":"10.1016\/j.cyto.2016.11.010_b0450","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1084\/jem.194.10.1497","article-title":"The role of Interleukin (IL) -10 in the persistence of leishmania major in the skin after healing and the therapeutic potential of anti \u2013 IL-10 receptor antibody for sterile cure","volume":"194","author":"Belkaid","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2016.11.010_b0455","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1046\/j.1365-2958.1998.00786.x","article-title":"High-frequency intracellular infection and erythrogenic toxin A expression undergo phase variation in M1 group A streptococci","volume":"28","author":"Cleary","year":"1998","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.cyto.2016.11.010_b0460","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CMR.13.3.470","article-title":"Pathogenesis of Group A streptococcal infections","volume":"13","author":"Cunningham","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.cyto.2016.11.010_b0465","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1128\/IAI.71.9.5376-5380.2003","article-title":"Intracellular survival of streptococcus pyogenes in polymorphonuclear cells results in increased bacterial virulence","volume":"71","author":"Medina","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2016.11.010_b0470","doi-asserted-by":"crossref","first-page":"22666","DOI":"10.1074\/jbc.M109.100131","article-title":"Specific behavior of intracellular streptococcus pyogenes that has undergone autophagic degradation is associated with bacterial streptolysin O and host small G proteins Rab5 and Rab7","volume":"285","author":"Sakurai","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cyto.2016.11.010_b0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2016.07.003","article-title":"Cytokine & growth factor reviews opposing roles of IL-10 in acute bacterial infection $","author":"Pe\u00f1aloza","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cyto.2016.11.010_b0480","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12026-009-8150-5","article-title":"Cell type-specific regulation of IL-10 expression in inflammation and disease","volume":"47","author":"Hedrich","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.cyto.2016.11.010_b0485","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1128\/IAI.00047-11","article-title":"Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens","volume":"79","author":"Cyktor","year":"2011","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cyto.2016.11.010_b0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003454","article-title":"CD4 T cell-derived IL-10 promotes brucella abortus persistence via modulation of macrophage function CD4+ T Cell-derived IL-10 promotes brucella abortus persistence via modulation of macrophage function","volume":"9","author":"Xavier","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cyto.2016.11.010_b0495","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.4049\/jimmunol.181.8.5545","article-title":"Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA\/J mice","volume":"181","author":"Beamer","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0500","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/infdis\/174.5.994","article-title":"Interleukin-10 impairs host defense in murine pneumococcal pneumonia","volume":"174","author":"van der Poll","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cyto.2016.11.010_b0505","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4049\/jimmunol.162.1.392","article-title":"IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense","volume":"162","author":"Steinhauser","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0510","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/art.1780380115","article-title":"Elevated interleukin-10 levels in patients with rheumatoid arthritis","volume":"38","author":"Cush","year":"1995","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2016.11.010_b0515","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1136\/gut.2003.029736","article-title":"Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection","volume":"53","author":"Rad","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.cyto.2016.11.010_b0520","first-page":"422","article-title":"Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women","volume":"31","author":"Padyukov","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.cyto.2016.11.010_b0525","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1536\/ihj.46.397","article-title":"Lack of association of genetic polymorphisms in the interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 genes with risk of rheumatic heart disease in Taiwan Chinese","volume":"46","author":"Chou","year":"2005","journal-title":"Int. Heart J."},{"key":"10.1016\/j.cyto.2016.11.010_b0530","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cyto.2012.10.020","article-title":"A study on the association of TNF-\u03b1(-308), IL-6(-174), IL-10(-1082) and IL-1Ra(VNTR) gene polymorphisms with rheumatic heart disease in Pakistani patients","volume":"61","author":"Rehman","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2016.11.010_b0535","first-page":"1","article-title":"Association of IL-4 (intron 3) and IL-10 (-1082) gene polymorphisms with risk of mitral valve disease in children with rheumatic heart disease","volume":"4","author":"Yousry","year":"2015","journal-title":"Cardiol. Young."},{"key":"10.1016\/j.cyto.2016.11.010_b0540","first-page":"33","article-title":"Gene polymorphisms of TNF-\u03b1 and IL-10 related to rheumatic heart disease","volume":"11","author":"Tawfik","year":"2010","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"10.1016\/j.cyto.2016.11.010_b0545","first-page":"1","article-title":"IL10 promoter polymorphisms are associated with rheumatic heart disease in Saudi Arabian patients","author":"Abdallah","year":"2015","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.cyto.2016.11.010_b0550","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1081-1206(10)63052-9","article-title":"Interleukin-10: biology, role in inflammation and autoimmunity","volume":"79","author":"Lalani","year":"1997","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0555","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/jlb.61.4.389","article-title":"Studies with IL-10\u2212\/\u2212 mice: an overview","volume":"61","author":"Rennick","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2016.11.010_b0560","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1084\/jem.185.12.2101","article-title":"Altered immune responses in interleukin 10 transgenic mice","volume":"185","author":"Hagenbaugh","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cyto.2016.11.010_b0565","first-page":"529","article-title":"The therapeutic potential of interleukin 10 in infection and inflammation","volume":"48","author":"Kumar","year":"2000","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.cyto.2016.11.010_b0570","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.4049\/jimmunol.169.4.2148","article-title":"IL-10 regulates murine lupus","volume":"169","author":"Yin","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0575","first-page":"283","article-title":"Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus","volume":"16","author":"Park","year":"1998","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cyto.2016.11.010_b0580","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10875-007-9104-0","article-title":"Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus","volume":"27","author":"Chun","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0585","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/1529-0131(200008)43:8<1790::AID-ANR15>3.0.CO;2-2","article-title":"Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus","volume":"43","author":"Llorente","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cyto.2016.11.010_b0590","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaci.2010.12.1087","article-title":"Current and novel therapeutics in the treatment of systemic lupus erythematosus","volume":"127","author":"Yildirim-Toruner","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cyto.2016.11.010_b0595","unstructured":"F. Osterroth, C. Uherek, C. Bruecher, P. Rattgen, B. Daelken, A. Engling, et al., Humanized anti-IL-10 antibodies for the treatment of systemic lupus erythematosus (SLE), 2 (2014). Patent US 20120321617A1."},{"key":"10.1016\/j.cyto.2016.11.010_b0600","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.179.1.305","article-title":"Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB\/W F1 mice","volume":"179","author":"Ishida","year":"1994","journal-title":"J. Exp. Med."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616305683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466616305683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:51:38Z","timestamp":1760907098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466616305683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":119,"alternative-id":["S1043466616305683"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2016.11.010","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interleukin-10: Role in increasing susceptibility and pathogenesis of rheumatic fever\/rheumatic heart disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2016.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}